The story of Viagra, and its parent company copyright, presents a intriguing case study for investors. Initially a blockbuster drug, generating billions in income, its exclusivity period created a wave of https://livebookmarking.com/story21400034/copyright-s-pill-and-the-pharmaceutical-sector-a-uncertain-investment